TIOTROPIUM BROMIDE | A211287 | LUPIN INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. LUPIN ATLANTIS HOLDINGS SA et al 4 patentsANDA 211287tiotropium bromide | D.N.J. | 2018-11-30 | Terminated 2019-03-15 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc. (Ropes & Gray, LLP) - Citizen Peti... FDA-2012-P-1072 · 6 docket documents Boehringer Ingelheim Pharmaceuticals, Inc. filed this citizen petition on October 13, 2012, requesting that the FDA adopt specific requirements for review and approval of proposed generic and follow-on versions of SPIRIVA HandiHaler (tiotropium bromide) under Sections 505(j) and 505(b)(2) of the Fed | 505(q) | 2012-11-15 | Partially Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$11.68
per ea
Lowest NADAC/Unit
$11.68
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68180096412TIOTROPIUM 18 MCG CAP-INHALER | $11.68 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.